サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1480365

がん診断の世界市場：2033年までの機会と戦略

Cancer Diagnostics Global Market Opportunities And Strategies To 2033
出版日: | 発行: The Business Research Company | ページ情報: 英文 313 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
がん診断の世界市場：2033年までの機会と戦略
出版日: 2024年05月16日
発行: The Business Research Company
ページ情報: 英文 313 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のがん診断市場は2018年に167億7,881万米ドルと評価され、2023年までCAGR4.0％以上で成長しました。

個別化医療に対する需要の増加

個別化医療に対する需要の増加は、がん診断市場の成長を促進しました。個別化医療は、精密医療や個別化医療とも呼ばれ、患者一人ひとりの特性に合わせた治療や介入を目指す医療へのアプローチです。個別化医療は、ゲノム・プロファイリング、標的治療、予測バイオマーカー、精密画像診断、臨床判断支援、医薬品開発におけるイノベーションを活用することで、がん診断を強化します。例えば、2022年10月の個別化医療連合（米国を拠点とし、科学者、患者、医療提供者を代表し、患者と医療制度に利益をもたらす個別化医療の理解と導入を促進する組織）の推定によると、複数のタイプのがん、遺伝的希少疾患、さまざまな慢性疾患や感染症の患者を対象に、75,000を超える遺伝子検査製品と300を超える個別化医薬品が市場に出回っています。そのため、個別化医療に対する需要の増加ががん診断市場の成長を支えています。

目次

第1章 エグゼクティブサマリー

  • がん診断-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • がん診断市場定義とセグメンテーション
  • 市場セグメンテーション：方法別
    • 生検
    • 内視鏡検査
    • 腫瘍バイオマーカー検査
    • イメージング
    • その他の方法
  • 市場セグメンテーション：用途別
    • 子宮頸がん
    • 乳がん
    • 肺がん
    • 脳および中枢神経系のがん
    • 腎臓がん
    • 大腸がん
    • 前立腺がん
    • 卵巣がん
    • 胃がん
    • その他の用途
  • 市場セグメンテーション：エンドユーザー別
    • がん研究機関
    • 診断ラボ
    • 病院
    • その他のエンドユーザー

第7章 がん診断市場：マクロ経済シナリオ

  • COVID-19の影響：がん診断市場
  • ウクライナ戦争の影響：がん診断市場
  • 高インフレの影響：がん診断市場

第8章 主要な市場動向

  • 自動診断ソリューションを提供するための技術の進歩
  • がん診断におけるイノベーションを推進する戦略的提携と買収
  • がん検出のための血液循環バイオマーカーの開発
  • がん診断におけるAIベースのツールに注目

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028

第10章 世界のがん診断市場：セグメンテーション

  • 世界のがん診断市場：方法別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のがん診断市場：用途別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のがん診断市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 がん診断市場：地域・国別分析

  • 世界のがん診断市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のがん診断市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Thermo Fisher Scientific Inc.
  • F. Hoffman-La Roche Ltd
  • Abbott Laboratories
  • Illumina Inc.
  • Hologic Inc

第20章 競合ダッシュボード

第21章 主要な合併と買収

  • Quest Diagnostics Acquired Haystack Oncology Inc.
  • Agilent Technologies Inc. Acquired Biomed Inc.
  • Thermo Fisher Scientific Inc. Acquired The Binding Site Group
  • Hologic Inc. Acquired Biotheranostics Inc.
  • Illumina Inc. Acquired GRAIL

第22章 機会と戦略

  • 2028年の世界のがん診断市場：新たな機会を提供する国
  • 2028年の世界のがん診断市場：新たな機会を提供するセグメント
  • 2028年の世界のがん診断市場：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第23章 がん診断市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第24章 付録

目次
Product Code: o&s1165

Cancer diagnosis refers to the process of identifying and determining the presence, type, extent and characteristics of cancer in a patient. This involves a variety of diagnostic techniques and tools aimed at detecting cancer, determining its stage and grade and guiding treatment decisions.

The cancer diagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of cancer diagnostics technologies and methods that detect substances that may indicate the presence of cancer in the body.

The global cancer diagnostics market was valued at $16,778.81 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 4.0%.

Increase In Demand For Personalized Medicine

An increase in demand for personalized medicine propelled the growth of the cancer diagnostics market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Personalized medicine enhances cancer diagnostics by leveraging genomic profiling, targeted therapies, predictive biomarkers, precision imaging, clinical decision support and innovation in drug development. For instance, in October 2022, according to the Personalized Medicine Coalition's (US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system) estimates, more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Therefore, the increase in demand for personalized medicine supported the growth of the cancer diagnostics market.

Focus On AI-Based Tools In Cancer Diagnosis

Major companies in the cancer diagnostics market are focusing on developing AI-based tools by leveraging machine learning algorithms and big data analytics to improve accuracy, speed, and efficiency. For instance, in April 2023, Google Health, a UK-based platform that provides applications and technologies for healthcare and medical research, offering AI and machine vision technology for various health-related purposes, including skin condition and breast cancer research assistance, was actively involved in developing AI tools for cancer detection and diagnosis, leveraging machine learning algorithms to analyze medical images and improve diagnostic accuracy., Further, in July 2023, IBM, a US-based medical technology company, leveraged artificial intelligence (AI) to aid in cancer diagnostics by analyzing extensive data to offer insights for personalized treatment strategies. The use of AI in healthcare, particularly in cancer diagnosis, holds promise for enhancing patient care and treatment outcomes, but it also underscores the importance of thorough evaluation and refinement to ensure the accuracy and effectiveness of AI-driven tools in clinical settings.

The global cancer diagnostics market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up 13.16% of the total market in 2022.

Cancer Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cancer diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for cancer diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cancer diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cancer diagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by method, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the cancer diagnostics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by method, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for cancer diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Method: Biopsy, Endoscopy; Tumor Biomarker Tests; Imaging; Other Methods
  • 2) By Application: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach Cancer; Other Applications
  • 3) By End User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc; F. Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Illumina Inc.; Hologic Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cancer diagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Cancer Diagnostics - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Cancer Diagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Method
    • 6.4.1 Biopsy
    • 6.4.2 Endoscopy
    • 6.4.3 Tumor Biomarker Tests
    • 6.4.4 Imaging
    • 6.4.5 Other Methods
  • 6.5 Market Segmentation By Application
    • 6.5.1 Cervical Cancer
    • 6.5.2 Breast Cancer
    • 6.5.3 Lung Cancer
    • 6.5.4 Brain And Central Nervous System Cancer
    • 6.5.5 Kidney Cancer
    • 6.5.6 Colorectal Cancer
    • 6.5.7 Prostate Cancer
    • 6.5.8 Ovarian Cancer
    • 6.5.9 Stomach Cancer
    • 6.5.10 Other Applications
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Cancer Research Institutes
    • 6.6.2 Diagnostic Laboratories
    • 6.6.3 Hospitals
    • 6.6.4 Other End-Users

7 Cancer Diagnostics Market - Macro Economic Scenario

  • 7.1 COVID-19 Impact On The Cancer Diagnostics Market
  • 7.2 Impact Of The War In Ukraine On The Cancer Diagnostics Market
  • 7.3 Impact Of High Inflation On The Cancer Diagnostics Market

8 Major Market Trends

  • 8.1 Technological Advancements To Provide Automated Diagnostics Solutions
  • 8.2 Strategic Partnerships And Acquisitions To Drive Innovation In Cancer Diagnostics
  • 8.3 Developments In Blood-Borne Circulating Biomarkers For Cancer Detection
  • 8.4 Focus On AI-Based Tools In Cancer Diagnosis

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Cancer Diagnostics Market Segmentation

  • 10.1 Global Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Cancer Diagnostics Market, Regional and Country Analysis

  • 11.1 Global Cancer Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Cancer Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.2 62
    • 12.1.3 62
    • 12.1.4 62
    • 12.1.5 Background Information
    • 12.1.6 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Cancer Diagnostics Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.1.13 Country Information
    • 12.1.14 Market Information
    • 12.1.15 Background Information
  • 12.8 75
  • 12.9 75
    • 12.9.1 75
    • 12.9.2 75
    • 12.9.3 75
    • 12.9.4 Government Initiatives
    • 12.1.16 Regulations
    • 12.1.17 Regulatory Bodies
    • 12.1.18 Major Associations
    • 12.1.19 Taxes Levied
    • 12.1.20 Corporate Tax Structure
    • 12.1.21 Investments
    • 12.1.22 Major Companies
  • 12.1 China Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Cancer Diagnostics Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Cancer Diagnostics Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Cancer Diagnostics Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Cancer Diagnostics Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Thermo Fisher Scientific Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 F. Hoffman-La Roche Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Abbott Laboratories
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Illumina Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Hologic Inc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Dashboard

21 Key Mergers And Acquisitions

  • 21.1 Quest Diagnostics Acquired Haystack Oncology Inc.
  • 21.2 Agilent Technologies Inc. Acquired Biomed Inc.
  • 21.3 Thermo Fisher Scientific Inc. Acquired The Binding Site Group
  • 21.4 Hologic Inc. Acquired Biotheranostics Inc.
  • 21.5 Illumina Inc. Acquired GRAIL

22 Opportunities And Strategies

  • 22.1 Global Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 22.2 Global Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 22.3 Global Cancer Diagnostics Market In 2028 - Growth Strategies
    • 22.3.1 Market Trend Based Strategies
    • 22.3.2 Competitor Strategies

23 Cancer Diagnostics Market, Conclusions And Recommendations

  • 23.1 Conclusions
  • 23.2 Recommendations
    • 23.2.1 Product
    • 23.2.2 Place
    • 23.2.3 Price
    • 23.2.4 Promotion
    • 23.2.5 People

24 Appendix

  • 24.1 Geographies Covered
  • 24.2 Market Data Sources
  • 24.3 Research Methodology
  • 24.4 Currencies
  • 24.5 The Business Research Company
  • 24.6 Copyright and Disclaimer